When comparing the relationship between the IS group and SM group and the severity of a stroke, we found that IS patients had significantly higher serum GFAP, NFL, OCLN, Claudin-5, and ZO-1 levels in both groups as compared to SMs (Figure 2A,C–F). This evidence concerns the gene CLDN5 and stroke disorder.